Driehaus Capital Management LLC Cytokinetics Inc Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $5.92 Million - $18.4 Million	220,384 New	220,384 $18.4 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $33,660 - $46,121	-1,009 Reduced 0.28%	365,348 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $44.4 Million - $63.4 Million	-1,239,957 Reduced 77.19%	366,357 $16.8 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.59 Million - $2.25 Million	-41,340 Reduced 2.51%	1,606,314 $77.8 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $8.13 Million - $11.7 Million	-239,509 Reduced 12.69%	1,647,654 $64.7 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $13.1 Million - $20.2 Million	-439,949 Reduced 18.91%	1,887,163 $69.5 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $19.3 Million - $26.1 Million	-562,414 Reduced 19.46%	2,327,112 $106 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $3.9 Million - $7.51 Million	-210,131 Reduced 6.78%	2,889,526 $103 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $2.69 Million - $3.67 Million	-135,981 Reduced 4.2%	3,099,657 $61.3 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $168,448 - $232,943	9,071 Added 0.28%	3,235,638 $75.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $2.97 Million - $5.58 Million	194,869 Added 6.43%	3,226,567 $67 Million
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $1.6 Million - $2.25 Million	-77,674 Reduced 2.5%	3,031,698 $65.6 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $1.51 Million - $3.35 Million	135,770 Added 4.57%	3,109,372 $73.3 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $574,472 - $1.07 Million	-65,654 Reduced 2.16%	2,973,602 $35.1 Million
Q4 2019 Feb 12, 2020	BUY	$7.95 - $11.84 $2.54 Million - $3.78 Million	319,091 Added 11.73%	3,039,256 $32.2 Million
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $5.76 Million - $7.59 Million	532,551 Added 24.34%	2,720,165 $31 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $17.4 Million - $24.6 Million	2,187,614 New	2,187,614 $24.6 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$699 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$561 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$462 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$371 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$308 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.49B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account